RP

Roger Perlmutter

Chairman, President, and CEO

Eikon Therapeutics

Hayward, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Eikon Therapeutics
Industry
research
Employees
400.0
Seniority
C suite
Annual Revenue
5600000.0
Total Funding
1122500000.0
Latest Funding
Series D

Technologies

Amazon SES Outlook Atlassian Cloud Greenhouse.io Webflow WordPress.org Google Maps Google Font API Jobvite Google Tag Manager Mobile Friendly Remote AI

Keywords

biotechnology research biotechnology drug discovery advanced engineering clinical development therapeutic pipeline solid tumors immunology neuroscience molecular biology preclinical programs high-throughput single-molecule tracking pharmacokinetics biomarkers serious diseases targeted therapies oncology research teams drug development cellular mechanisms innovative therapeutics real-time imaging drug interaction therapeutic modalities scientific research cell dynamics cancer therapies clinical programs engineered solutions precision medicine safety reporting healthcare conference nimble operations molecule screening protein dynamics drug targets patient-centric technology integration data analysis high-throughput strategies clinical research drug evaluation translational research target engagement biopharmaceuticals scientific innovation cell biology genetic research drug formulation safety assessments super-resolution microscopy single molecule tracking tlr7/8 agonist parp1 inhibitors live-cell imaging automation high-performance computing clinical trials advanced drug development healthcare providers pharmaceutical companies research institutions global presence diverse expertise breakthrough therapeutics patient outcomes cancer treatment advanced technologies drug development ecosystem investors strategic partnerships hospital & health care data analytics health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans